Based on previous studies, we hypothesize that: (1) LAG3 expression varies among histological and molecular subtypes of GC, and (2) high density of LAG3 + cells is related to advanced clinicopathological features and poor outcome in GC. The gene discussed is LAG3; the disease is gastric cancer.